Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Previous ID Grand Rounds 2010 Professor of Radiology, Director, Division of Nuclear Medicine, UC Denver 1/27/10 William Klingensmith, MD Imaging Infection with FDG & PET-CT: The Best Imaging Study for Infection 2/10/10 Robert Belknap, MD Assistant Professor, INFgamma Release Assays for Division of Infectious Diagnosis of TB Diseases - UC Denver 2/17/10 3/3/10 3/10/10 3/31/10 4/7/10 5/5/10 Assistant Research Scientist, Assistant Professor Epidemiology Department, Colorado School of Public Health Alia Al-Tayyib, PhD HIV Behavioral Surveillance Project Kevin High, MD Professor of Medicine, HIV and Aging: Pathogenesis, Chief, Section of Outcomes and Future Infectious Diseases, Research Priorities Wake Forest University Richard Haubrach, MD Regimens for Treatment Experienced HIV-Infected Patients: Which Agents, How Many and Why (and How the Resistance Test Can Help) Carlos Del Rio, MD Professor/Chair - Hubert Department of Global Tim Gill Lecture Presentation: Health, Rollins School of Sex, Drugs, and HIV: The Public Health. Professor Synergistic Epidemics of Crack of Medicine in Infectious Cocaine and HIV Diseases at the Emory University School of Medicine Professor of Medicine, Division of Infectious Diseases, University of California, San Diego, CA Reuler-Lewin Family Professor and Chair of Neurology. Professor of Medicine, Microbiology and Immunology UC Denver Ken Tyler, MD West Nile Virus Neuroinvasive Disease Marinka Kartalija, MD Characterizing Body Morphotype and Serum Fellow, Infectious Adipokine & Cytokine Levels in Diseases, UC Denver Patients with Nontuberculosis Mycobacteruak (NTM) Lung Disease The use of EBV Lytic and Latency III mRNA and of Viral DNA for Early Detention of PTLD Fellow, Infectious Diseases, UC Denver 5/12/10 Jing Kroll, MD 6/2/10 Kristine Erlandson, MD Fellow, Infectious Diseases, UC Denver 6/16/10 Margaret McLees, MD Fellow, Infectious Diseases, UC Denver 2009 2/4/2009 Sam MaWhinney, PhD 4/1/2009 Trends in Shiga toxinAlicia Cronquist, producing E. Coli (STEC) RN, MPH Infection Statistics 101 Professor, Preventive Medicine and Biostatistics – UC Denver Foodborne/Enteric Disease Epidemiologist. CO Dept. of Public Health and Environment Associate Professor, Division of Hematology & Oncology, UCLA David Geffen School of Medicine 5/6/2009 Beth Jamieson, PhD The Dual Impact of HIV and Age on T-Cells; Why getting HIV makes you old 6/3/2009 Vivian Cox, MD HIV-1 Infection of Follicular CD4+ Lymphocites ID Fellow – UC Denver 8/12/2009 Mary Kestler, MD TB/HIV Education and Care Program for Health Care Workers in Botswana Head, TB/HIV Program, Botswana-University of Pennsylvania 8/19/2009 Joshua Metabolic Drug Targets in TB Christensen, MD Current Challenges and Evolving Concepts in the Management of Invasive Fungal Infections in Solid Organ Transplant Recipients ID Fellow, UC Denver Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh 9/9/2009 Nina Singh, MD 9/16/2009 Risk Factors of Clostridium Eric Kajioka, MD Difficile Infection in Hospitalized Adults ID Fellow, UC Denver 9/30/2009 Charles Steinberg, MD Consultant and Trainer, ID Institute AIDS in Africa, One Colorado Doctor’s Experience 11/11/2009 Dan Bausch, MD Challenges to Diagnosis the Viral Hemorrhagic Fevers Associate Professor, Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine 2008 Date Speaker 1/10/2008 Topic HIV Lipoatrophy Medical Director, Associate Professor, Department of Dermatology, UC Denver The Current Increase in Syphillis STD/HIV Section Chief, CDPHE Theresa Pacheco, MD 1/17/2008 1/24/2008 Ralph Wilmoth Pathogenic Mechanisms and Antimicrobial Treatment of Dennis Stevens, Toxin Related Infections MD, PhD Caused by Gram Positive Microbes 1/31/2008 David Margolis, MD 2/14/2008 2/21/2008 3/6/2008 3/13/2008 William Claude Klingensmith, MD Dan Kuritzes, MD 3/20/2008 Professor of Medicine, University of Washington Mechanisms that Maintain HIV Latency: Targets for Future Therapeutics to Eradicate Persistent Infection Professor of Medicine, Microbiology and Immunology, Epidemiology, University Of North Carolina at Chapel Hill Imaging Infection with FDG & PET-CT Director, Hewit Biomolecular Imaging Center, Porter Hospital HIV-1 Entry, Chemokine Receptors, and CCR5 Antagonists Glenn Treisman, HIV and Depression MD, PhD Thomas Gootz, MD Affiliation/Contact Professor of Medicine, Harvard Medical School Director of HIV Mental Health, Johns Hopkins Carbapenem-Resistance in Klebisiella Pneumoniae, a Global Problem Department of Antibiotics, Immunology, and Cancer, Pfizer Hepatitis C Professor of Medicine, Division Head of Gastroenterology, UC Denver Hugo Rosen, MD 4/10/2008 Edward Gardner, MD HIV and Medication Adherence Assistant Professor of ID, UC Denver 4/17/2008 Rohini Sharma, MD Staphylococcus and Epidural Abscesses ID Fellow, UC Denver 5/1/2008 Rawleigh Howe, MD Dendritic Cells and HIV 5/15/2008 Minal Kapoor, MD Central Blood Stream Infection Prevention ID Fellow, UC Denver ID Fellow, UC Denver 5/22/2008 6/5/2008 6/12/2008 6/18/2008 Daniel Musher, MD Timothy Jenkins, MD CA-MRSA USA300 Bloodstream Infections in Denver’s Health Care System Professor of Medicine, Baylor University ID Fellow, UC Denver The Role of Antibiotics in Carla Saveli, MD Open Fractures in the Era of CA-MRSA ID Fellow, UC Denver Mary Kestler, MD Delays in the Diagnosis of Tuberculosis ID Fellow, UC Denver Michelle Haas, MD HIV-1 Infection of FollicularCD4+ cells may be associated with increased BClID Fellow, University of 2 levels and affect cell Colorado Denver survival: Implications for persistent viral replication in lymphoid tissues 9/3/2008 10/1/2008 Syphillis David Cohn, MD TB Infection Control in Resource Limited Settings; Can it Be Done? Professor of Medicine, Denver Health Hospital Douglas Fish, 10/15/2008 PharmD Antimicrobial Pharmacodynamics: Assessing the role of Monte Carlo Simulation Professor, School of Pharmacy 10/29/2008 Jerry Nick, MD Neutrophil-induced enhancement of Pseudomonas aeruginosa biofilms Assistant Professor, Division of Pulmonary Medicine, National Jewish Center 12/3/2008 Donald Gilden, MD Professor, Department of Microbiology, UC Denver 2007 Date Speaker Topic Affiliation/Contact 1/11/2007 Elizabeth Connick, M.D. Primary HIV-1 Infection UCD 1/18/2007 Edward Chan, M.D. The skinny on Mycobacterium abscessus infection UCD 2/1/2007 Thomas HHV-8 Infection and Campbell, M.D. Kaposi’s Sarcoma 2/15/2007 Peter Palese 2/22/2007 Prevention of HIVEd Janoff, M.D. associated Bacterial Pneumonia 3/8/2007 Gary Doern, M.D. Methicillin Resistant Staphylococcus aureus – The Coming Storm University of Iowa 4/5/2007 Shannon Kasperbauer, M.D. Pulmonary Mycobacterium Avium Complex UCD 4/12/2007 Timothy Jenkins, M.D. Evaluation and Classification of Staphylococcus aureus UCD Bacteremia 4/19/2007 John Quinn, M.D. Emerging Issues of Resistance in GramNegative Bacteria 4/26/2007 Caring for Sondra Crosby, Refugee/Immigrant Women M.D. with HIV Boston University Medical Center 5/3/2007 Joseph Morroni, Biofilms: not just a sticky M.D. mess UCD 5/10/2007 David Treatment of Viral Beckham, M.D. Encephalitis UCD 5/17/2007 Judith Currier, M.D. Atherosclerosis and Metabolic Complications of HIV Infection 5/31/2007 Kristin Brousseau, D.O. Cognitive Impairment in the UCD Aging HIV+ Patient 8/16/2007 Eoin Coakley, MD Influenza Virus Pandemics: Past and Future UCD Mount Sinai School of Medicine UCD Professor of Medicine, Rush University Tim Gill Lecture Senior Medical Director, Clinical Research, The Royal College of Surgeons, Dublin, Ireland 9/6/2007 William Burman, MD New TB Medications Denver Health, UC Denver 9/13/2007 Priscilla Hsue, MD HIV and Cardiac Disease HCSF 9/27/2007 Mark Schaefer, ParmD Personalized Medicine: Are We There Yet? GSK, Group Director HIV 10/4/2007 Derrick Fine, MD HIV and Kidney Disease Johns Hopkins University Infection Control Johns Hopkins University 10/18/2007 Trish Perl, MD 11/1/2007 Bruce Mc Collister, MD Antibiotic Tolerance UC Denver 11/8/2007 Amiee Zaas, MD Treating Invasive Fungal Infections in The Immunocompromised Patient Duke University Lionel Mandell, 11/15/2007 MD 12/6/2007 The New ATS/IDSA Guidelines for the McMaster University Management of CommunityAcquired Pneumonia Future Directions for MRSA Daniel Perlman, Infections/New Diagnostic MD Tools and New Antimicrobials Greater Denver Infectious Disease Specialists 2006 Date Speaker Title Affiliation 1/5/2006 Randall Reeves, M.D. The Skinny on TB: Anorexia, Debility, Nutrition or Phenotypic UCD/DHHA Risk Factors? 1/12/2006 Stanley Louie, Ph.D. Clinical Impact of Blockade Cellular Transporters in HIV Arena 2/2/2006 Marilyn Levi, M.D. BK polyomavirus and transplantation UCD 2/16/2006 Ches Thompson, M.D. Epidemiology and Clinical Burden of Human Papillomavirus (HPV) UCD 2/23/2006 Mary Ann DeGroote MapQuest, the enduring hunt for M. paratuberculosis in Crohn's UCD 3/2/2006 Herbert DuPont, M.D. New Developments in Travelers' University of Houston Diarrhea 3/9/2006 HIV Neurobehavioral Management of Central Nervous Scott Letendre, Research Center and System Complications of HIV M.D Antiviral Research Infection Center, UCSD 3/30/2006 Peter A Leone, MD 4/6/2006 Lyle R. Petersen, M.D., West Nile Virus in the Americas M.P.H. 4/13/2006 Robert Bonomo, M.D. 4/20/2006 Richard Martin, Asthma is an infectious Ph.D disease.” 4/27/2006 Milene Management of Patients with CF UCD Saavedra, M.D. 5/4/2006 The MTCT-Plus Program: Lessons Learned and Practical Wafaa El-Sadr, Aspects of Antiretroviral M.D., MPH Therapy in Resource-Poor Settings Harlem Hospital and Columbia U 5/11/2006 Ellie Schoenbaum, Montefiore Medical Center/Albert Einstein The North Carolina Acute HIV Program: Screening and Tracing the Transmission of HIV Antimicrobial Resistance and the Management of Serious Infections Menopause and Beyond: HIV in Older Women UNC-Chapel Hill Division of Vector-borne Infectious Diseases, Center for Disease Control and Prevention Case Western Reserve School of Medicine National Jewish Medical and Research Center MD College of Medicine 5/18/2006 Lisa Young, M.D. UCD 6/1/2006 Amie Meditz, M.D. Projects Exploring Why Women Have Lower HIV-1 Viral Loads Early in Disease UCD 6/8/2006 David Mechanisms of Disease in Viral Beckham, M.D. Encephalitis UCD 6/22/2006 Myron Levin, M.D. Herpes Zoster: Pathogenesis and Prevention UCD 9/7/2006 Connie Price, M.D. The Dying Prosthesis…and other Dilemmas in Orthopedic Device- UCD/DHHA Related Infections 9/14/2006 Whitney High, M.D. Tropical Medicine and Cutaneous Disease in the Returning Traveler UCD 9/21/2006 Kieran Marr, M.D. Fungal Infections in Immunocompromised Adults University of Washington 10/5/2006 Mark Abzug, M.D. The Enteroviruses: An Emerging UCD Infectious Disease 10/19/2006 Peter ChinHong, M.D. HPV in MSM UCSF 10/26/2006 Michelle Roland, M.D. Post-exposure Prophylaxis UCSF 11/2/2006 Jeff Lennox, M.D. Research Strategies to care for the Impossibly Difficult Patient Emory University 11/16/2006 Andy Zolopa, M.D. HIV Resistance and Clinical Implications Stanford University 12/7/2006 Dale Gerding, M.D. C. difficile Loyola University 2005 Date Speaker Title Affiliation 1/6/2005 Kathyrn Holmes, Ph.D. SARS Update 2005 UCD 1/20/2005 Michael Wong, M.D. Update in SOT in HIV+ Recipients ID Beth Israel Deaconess/Harvard 1/27/2005 Sarah Parker, M.D. Vaccines and autism: understanding UCD the controversy 2/3/2005 Alicia Cronquist Foodborne Disease Epidemiology CDPHE 2/10/2005 Cara Wilson, M.D. Update of the EP-1090 HIV-1 DNA Therapeutic Vaccine Trial UCD 2/17/2005 Monica Carten, M.D. HIV Post-Exposure Prophylaxis for nonoccupational exposures UCD 3/3/2005 Susan Metabolic Complications of HIV Swindells, M.D. Disease and Its Therapies University of Nebraska 3/10/2005 Princy Kumar, M.D. Georgetown University 3/17/2005 Leland Shapiro, Anthrax! Bacterial Pathogenesis and UCD M.D. Novel Approach to Treatment 3/31/2005 Megan Clancy, M.D. Clostridium difficile…Fact and Fiction UCD 4/14/2005 Alison Elliott, M.D. The impact of helminth infection in pregnancy on the response to immunisation and on disease incidence in infancy: preliminary results from a continuing intervention trial. London School of Hygiene and Tropical Medicine 4/21/2005 Bob Belknap, M.D. the Law & Order of TB Control in 2005 UCD 5/5/2005 Kathryn Robertson, M.D. "Dendritic Cell Phenotype and UCD Function in HIV-1-infected Patients" 5/12/2005 Ruth Berggren, MD Sealing it up and rolling it out: HIV care in resource poor countries.” Tulane University 5/19/2005 Mark Abzug, M.D. Pneumococcal Vaccination and Immune Reconstitution in HIVInfected Children UCD 5/26/2005 Ed Gardner, M.D. "Is Risk-Based HIV Testing Effective? New Data from Denver Health" UCD 6/2/2005 Pam Skinner, PhD In situ analysis of HIV and SIV specific CD8+ T cells University of Minnesota HIV as a Chronic Disease 6/9/2005 Mark Cotton, M.B. HIV in children from the Western Cape, South Africa – from bad to worse to better 6/16/2005 William Burman, M.D. "You can't always get what you want, but if you try sometimes... - a UCD clinician's view of salvage antiretroviral therapy" 6/23/2005 Amie Meditz, M.D. Sex Differences in Plasma HIV-1 Concentrations: A pilot study to investigate HIV-1 Replication and CCR5 Expression in Lymphoid Tissue of Women compared to Men UCD 9/2/2005 Gary Dubin, M.D. HPV Vaccine GSK 9/8/2005 Kees Rietmeijer, M.D. Lymphogranuloma venerum among Men Who Have Sex With Men Denver Public Health 9/22/2005 Maggie Wierman, M.D. Metabolic Bone Disease in HIV patients UCD/Denver VAMC 9/29/2005 Cytomegalovirus Infection in the Adriana Era of HAART: Better Immunity and UCD Weinberg, M.D. Fewer Reactivations Stanley 10/20/2005 Derezinski, M.D. Minimizing Antibiotic Resistance: The Fluoroquinolones. Stellenbosch University Stanford Immunotherapy for Invasive Fungal Infections: Is There a Role in Univ of AL Clinical Care? 10/27/2005 Peter Pappas, M.D. 11/3/2005 Mary Bessesen, Nosocomial Aspergillosis M.D. UCD 11/17/2005 Greg Everson, M.D. UCD Antiviral Therapy of Advanced Hepatitis C: Pros and Cons 2004 Date Speaker Title Affiliation 1/8/2004 Philip Keiser, M.D. Utility of Cohort Comparisons of AntiUT Southwestern retroviral Regimens 1/15/2004 Jack Stapleton, GB Virus: A Major Factor in HIV M.D. Long Term Nonprogression Univ of Iowa 1/29/2004 Kevin High, M.D. Infection and Immunity in Older Adults Wake Forest University 2/5/2004 Norbert Voelkel Expression of HHV-8 in Primary Pulmonary Hypertension UCD 2/19/2004 Kathryn Lee, M.D. Resistant CMV in BMT Recipients UCD 3/4/2004 Marin Kollef, M.D. Optimization of the antibiotic therapy Washington for hospital-asasociated pneumonia University 3/18/2004 Megan Clancy, M.D. Community and Hospital Acquired MRSA Infections at Denver Health UCD 4/1/2004 Henry F. Chambers, M.D. Community MRSA UCSF 4/8/2004 Current Concepts on the Todd Kingdom, Pathophysiology of Chronic M.D. Rhinosinusitis 4/15/2004 Ken Thomson, Ph.D. 4/22/2004 Susan Cu Uvin, Gynecological Care: Concerns of HIVBrown University MD Infected Women Academic Perspectives in Emerging Issues of Resistance in GramNegative Bacteria UCD University of Nebraska 4/29/2004 Bill Burman, M.D. Invasive nocardiosis - Can we ever move beyond anecdotes in the treatment of unusual, but severe infectious diseases? 5/20/2004 David Wyles, M.D. HCV/HIV Co-infection Update and Beyond: In Vitro Activity and resistance to a HCV Serine Protease Inhibitor 5/27/2004 Andrew Pavia, M.D. Women, pregnancy and HIV: What University of Utah have we learned in the last 10 years. 6/3/2004 John Koeppe, M.D. HIV-1 specific T cell Responses in Viral Evolution – A Major Cause of Disease Progression? UCD 6/10/2004 Ed Gardner, M.D. Adherence to Antiretrovirals in the Denver Health System UCD 6/17/2004 Bruce Walker, UCD UCD Harvard University M.D. 6/24/2004 Robert Belknap, M.D. Tuberculosis Elimination: the Colorado Perspective UCD 9/9/2004 Michael Miller, Ph.D. Resistance, Replication Capacity and Intracellular Pharmacology of NRTIs Gilead 9/16/2004 Arturo Casadeval, M.D., Ph.D 'New insights into cryptococcal pathogenesis and development of antibody therapy' Albert Einstein College of Medicine 9/23/2004 J.J. Hakim, M.D. Impact of HIV Epidemic on Clinical Practice in Zimbabwe Tim McGill Annual Lecture 10/7/2004 Connie Price, M.D. Science and Superstitions in Infection Control UCD 10/14/2004 Jo-Anne van Burik, M.D. Antifungal prophylaxis: Clinical updates Univ of Minnesota Elizabeth 10/21/2004 Connick, M.D. Why Have Efforts To Augment HIVSpecific Immunity Failed to Result in UCD Virologic Control? New Insights From Lymphoid Tissue Studies 10/28/2004 Michelle Barron, M.D. 11/4/2004 Michael Interesting Case Presentations from Saubolle, Ph.D. the Southwest Deserts 11/11/2004 Mike Pfaller, M.D. Has Antifungal Testing Come of Age? University of Iowa 11/18/2004 John Perfect, M.D. Advancing the Art of Antifungal Therapy: New Therapeutic Options and Strategies 12/2/2004 Chris Petropoulos, Ph.D. A Closer Look at HIV-1 Co-Receptor Tropism in the Emerging Era of Entry Virologic Labs Inhibitors 12/9/2004 Alan T. Evangelista, Ph.D. Antimicrobial Resistance Trends and Appropriate use of Antibiotics Influenza in the 21st Century UCD University of Arizona Duke University Ortho-McNeil Pharmaceuticals 2003 Date Speaker Title Affiliation 1/9/2003 Thomas Patterson New Antifungal Agents: New Choices UTHSC-SA 1/16/2003 Dennis Maki The Need for a New Paradigm for Control of Nosocomial Infection in the ICU Univ of Wisconsin 1/23/2003 Frank Judson Bioterrorism: A Holistic Approach to Assessing Risk and Planning for Control UCD 1/30/2003 Steven Johnson West Nile Virus UCD 2/6/2003 Ed Abraham New Treatments for Sepsis UCD 2/20/2003 Judith Andersen History of the Plague UCD 2/27/2003 Nalini Rao An Update on the Diagnosis and Management of Osteomyelitis University of Pittsburgh 3/6/2003 Donna Sweet HIV care: A Perspective on Women University of Kansas 3/13/2003 Dan Kuritzkes HIV Drug Resistance: Strategic Implications for Therapy Harvard University 4/3/2003 Veronica Miller Definition of Treatment Failure George Washington University 4/10/2003 Ferric Fang Can We Treat Infectious Diseases by Modulating Host Defenses? University of Washington 4/17/2003 Joseph Falkinham Epidemiology and Ecology of Mycobacterium avium Virginia Polytechnic University 4/24/2003 Kathleen Squires Clinical Care Update: Antiretroviral USC Therapies for Women 5/1/2003 John Koeppe Mechanism of CD4+ T cell escape UCD 5/8/2003 Bill Burman Why isn't TB going away in Denver? Insights from conventional and molecular epidemiology UCD 5/15/2003 James Neid KSHV infection of pulmonary endothelial cells: clinical and laboratory significance UCD Mary Hamel The Effect of Daily Cotrimoxazole for the Prevention of HIV-Related Opportunistic Infections on the Development of Resistance in Common Pathogens in Africa CDC 5/22/2003 5/29/2003 David Wyles “Toward an in vitro system to characterize novel anti-HCV compounds UCD 6/5/2003 Mark Thrun HIV Prevention: Moving Beyond Condoms UCD 6/12/2003 Bruce McCollister Interferon-gamma in host defense against S. typhimurium UCD 6/19/2003 Kathryn Lee CMV-Specific Immune Reconstitution in BMT Patients UCD 6/26/2003 "Specific anti-cytokine therapies work but at the expense of Charles Dinarello decreased host defense against infection." 9/4/2003 Richard Ogden, Ph.D. HIV Resistance, Fitness, and Pathogenicity: Current Data and Ongoing Research Agouron 9/11/2003 Mike Iseman, M.D. Primum Non Nocere and RIF-PZA Treatment of Latent TB: Mutually Exclusive?" UCD 9/25/2003 Mark Sulkowski, M.D. HCV in the HIV-infected Patient Johns Hopkins 10/2/2003 Mahmoud A. Ghannoum, M.Sc., Ph.D. Candida Biofilms and the Role of Antifungals Case Western 10/16/2003 David Simpson, M.D. Neurological Complications of HIV Mt. Sinai 10/23/2003 S. Ferrando, M.D. Case Studies in HIV Cornell University 10/30/2003 Evolving Epidemiology of Fungal Dimitrios Infections with a Special Focus on Kontiannis, M.D. Candidemia MD Anderson 11/6/2003 Ken Lichtenstein, M.D. Antiretroviral Toxicities, An Alternative View Rose Medical Center 11/13/2003 Max Salfinger, M.D. HIV/TB Co-Infection Up-Date NY State Dept of Health 11/20/2003 Nelson Gantz, M.D. Chronic Fatigue Syndrome: Real or UCD/Boulder Imaginary 12/4/2003 Ken Tyler, M.D. West Nile Virus UCD Nucleoside Therapy in 2003; What Have We Learned and Where do we go From Here? GSK 12/11/2003 Marty St. Clair UCD